hypertrophic cardiomyopathy

Hypertrophic Cardiomyopathy In the News Newly Approved Technology

New AI algorithm for early detection of HCM receive a De Novo approval

iz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has received a De Novo approval by the U.S. Food and Drug Administration (FDA) for its…

Cardio Drug Hypertrophic Cardiomyopathy Newly Approved

Camzyos treat obstructive hypertrophic cardiomyopathy

Drug Approval Name: Camzyos Active Ingredient: mavacamten Indications: To treat certain classes of obstructive hypertrophic cardiomyopathy Approval Date: 4/28/2022 Company: MyoKardia, Inc., a wholly-owned subsidiary of Bristol Myers Squibb More: …